HCC Manager’s Inari Medical NARI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,914,246
Closed -$149M – 2
2024
Q4
$149M Hold
2,914,246
– – 93.92% 1
2024
Q3
$120M Hold
2,914,246
– – 91.04% 1
2024
Q2
$140M Hold
2,914,246
– – 80.23% 1
2024
Q1
$140M Buy
+2,914,246
New +$156M 80.17% 1

Other funds holding NARI

HCC Manager's NARI Position: Q1 2025 in Review

HCC Manager sold out of Inari Medical (NARI) in Q1 2025, closing a stake of 2,914,246 shares — an estimated $149M sold.

HCC Manager first reported a position in NARI in Q1 2024 and held it in 4 quarters. The position peaked at $149M in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • HCC Manager reported no remaining Inari Medical position as of Q1 2025 after selling out during the quarter.
  • HCC Manager sold 2,914,246 Inari Medical shares in Q1 2025, an estimated $149M.
  • HCC Manager first reported a position in Inari Medical in Q1 2024 and held it in 4 quarters.
  • HCC Manager's Inari Medical position peaked at $149M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical as of Q1 2025.

Based on HCC Manager's 13F filing for Q1 2025, filed 12 May 2025.